Normalization of anticardiolipin antibodies following rituximab therapy for marginal zone lymphoma in a patient with Sjögren's syndrome [5]

Rheumatology

Volumn 43, Issue 10, 2004, Pages 1309-1310

  Harner, Kyle C ^a   Jackson, L W ^a   Drabick, J J ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CARDIOLIPIN ANTIBODY; RHEUMATOID FACTOR; RITUXIMAB; WARFARIN;

ADULT; ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; BONE MARROW BIOPSY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; LABORATORY DIAGNOSIS; LETTER; LYMPHOMA; MAINTENANCE THERAPY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECURRENT CANCER; SJOEGREN SYNDROME;

ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE; MIDDLE AGED; SJOGREN'S SYNDROME; TREATMENT OUTCOME;

EID: 5444255031     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keh308     Document Type: Letter

References (10)

1. Kassan SS, Thomas TL, Moutsopoulos HM et al. Increased risk of lymphoma in sicca syndrome. Ann Intern Med 1978;89:888-92.
2. Asherson RA, Fei H, Staub HL, Khamashta MA, Hughes GRV, Fox RI. Antiphospholipid antibodies and HLA associations in primary Sjogren's syndrome. Ann Rheum Dis 1992;51:495-8.
3. Ingram SB, Goodnight SH Jr, Bennet RM. An unusual syndrome of a devastating noninflammatory vasculopathy associated with anticardiolipin antibodies: report of two cases. Arthritis Rheum 1987;30:1167-72.
4. Onida P, Tresoldi M, Rugarli C. Anti-phospholipid-antibody syndrome associated with peripheral T-cell lymphoma. Am J Hematol 1997;55:167-8.
5. Ciaudo M, Horellou MH, Audouin J et al. Lupus anticoagulant associated with primary malignant lymphoplasmacytic lymphoma of the spleen: a report of four patients. Am J Hematol 1991;38:271-6.
6. Sciarra, Stasi R, Stipa E et al. Antiphospholipid antibodies: their prevalence, clinical significance and correlation with cytokine levels in acute myeloid leukemia and non-Hodgkin's lymphoma. Recent Prog Med 1995;86:57-62.
7. Timuragaoglu A, Duman A, Ongut G, Saka O, Karadogan I. The significance of autoantibodies in non-Hodgkin's lymphoma. Leuk Lymphoma 2000;40:119-22.
8. McGuire D, Zeidman A, Mittelman M. Non-Hodgkin's lymphoma presenting with coagulopathy due to anti-phospholipid antibody syndrome. Leuk Lymphoma 1997;26:193-6.
9. Silverman GJ, Weisman S. Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapy. Arthritis Rheum 2003;48:1484-92.
10. Somer BG, Tsai DE, Downs L, Weinstein B, Schuster SJ. Improvement in Sjogren's syndrome following therapy with rituximab for marginal zone lymphoma. Arthritis Rheum 2003;49:394-8.